Abstract:There have been more than 2.2 million confirmed cases and over 120 000 deaths from the human coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), in the United States alone. However, there is currently a lack of proven effective medications against COVID-19. Drug repurposing offers a promising route for the development of prevention and treatment strategies for COVID-19. This study reports an integrative, network-based deep-learning methodology to identify repurposable drugs for COVID-19 (termed CoV-KGE). Specifically, we built a comprehensive knowledge graph that includes 15 million edges across 39 types of relationships connecting drugs, diseases, proteins/genes, pathways, and expression from a large scientific corpus of 24 million PubMed publications. Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials. Whereas this study by no means recommends specific drugs, it demonstrates a powerful deep-learning methodology to prioritize existing drugs for further investigation, which holds the potential to accelerate therapeutic development for COVID-19.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jproteome.0c00316?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00316</a>.Supplementary Figure 1. Diagram illustrating the prioritization of drugs based on their distance to COVID-19 in the treatment relation space. Supplementary Table 1. Details of the five categories of relationships in our KG. Supplementary Table 2. Statistics of nodes (entity) and edges (relation) in our KG (<a class="ext-link" href="/doi/suppl/10.1021/acs.jproteome.0c00316/suppl_file/pr0c00316_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19

Multi-omics study revealing putative drug targets of COVID-19 severity and other viral infection diseases

Multi-omics study revealing tissue-dependent putative mechanisms of SARS-CoV-2 drug targets on viral infections and complex diseases

An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics

Network-Based Approach to Repurpose Approved Drugs for COVID-19 by Integrating GWAS and Text Mining Data

A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19

Network-based Drug Repurposing for the Treatment of COVID-19 Patients in Different Clinical Stages

Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement

Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19.

In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19

Repurposing of Anti-Cancer Drugs Against Moderate and Severe COVID Infection: A Network-Based Systems Biological Approach

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network Analysis

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome

SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis

Drug repurposing prediction for COVID-19 using probabilistic networks and crowdsourced curation

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Recent computational drug repositioning strategies against SARS-CoV-2.

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates